Literature DB >> 10883463

Heparin reduces serum levels of endothelin-1 and hepatic ischemia reperfusion injury in rabbits.

T Matsumoto1, M Yamaguchi, H Kikuchi, H Nakano, T Midorikawa, K Kumada, M Takeda.   

Abstract

Since the role of heparin in hepatic ischemia/reperfusion (I/R) injury is still not fully understood, we investigated the effects of heparin on hepatic I/R injury in rabbits. Heparin was injected into rabbits after inducing partial hepatic ischemia for 1 h. Thereafter, the serum levels of endothelin-1 (ET-1) and liver transaminase, and tissue levels of oxidized and deoxidized hemoglobin (oxHb, deoxHb) in the reperfused liver were analyzed. Microscopic examinations were also performed. The increased serum levels of ET-1 and liver transaminase after reperfusion were significantly reduced by heparin (P > 0.01). Hepatic ischemia reduced oxHb and increased deoxHb. Reperfusion with heparin immediately reduced deoxHb and increased oxHb, and thereafter the balance between the two kinds of Hb also recovered. However, reperfusion without heparin did not demonstrate any similar recovery, but instead gradually exacerbated the dissociation. Microscopically, heparin appeared to normalize I/R-induced activation of hepatic stellate cells which are the target cells for ET-1. These results suggest that heparin improves the hepatic I/R injury caused by sinusoidal microscirculatory disturbances partly via an inhibition of the ET-1 increase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10883463     DOI: 10.1007/s005950070119

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Endothelin, a potent peptide agonist in the liver.

Authors:  C R Gandhi; K Stephenson; M S Olson
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

2.  Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide?

Authors:  C Koseki; M Imai; Y Hirata; M Yanagisawa; T Masaki
Journal:  Am J Physiol       Date:  1989-04

3.  Ito cell contraction in response to endothelin-1 and substance P.

Authors:  M Sakamoto; T Ueno; M Kin; H Ohira; T Torimura; S Inuzuka; M Sata; K Tanikawa
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

4.  Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction.

Authors:  T Miyauchi; M Yanagisawa; T Tomizawa; Y Sugishita; N Suzuki; M Fujino; R Ajisaka; K Goto; T Masaki
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  Quantitative detection of hemoglobin saturation in the liver with near-infrared spectroscopy.

Authors:  T Kitai; A Tanaka; A Tokuka; K Tanaka; Y Yamaoka; K Ozawa; K Hirao
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

6.  Plasma immunoreactive endothelin in essential hypertension.

Authors:  M Kohno; K Yasunari; K Murakawa; K Yokokawa; T Horio; T Fukui; T Takeda
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

7.  Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury.

Authors:  E Kawamura; N Yamanaka; E Okamoto; F Tomoda; K Furukawa
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

8.  Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells.

Authors:  K Yokokawa; H Tahara; M Kohno; A K Mandal; M Yanagisawa; T Takeda
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Heparin lowers the blood pressure in hypertensive rats.

Authors:  D Susic; A K Mandal; D Kentera
Journal:  Hypertension       Date:  1982 Sep-Oct       Impact factor: 10.190

10.  The endothelin-1 binding site in rat liver tissue: light- and electron-microscopic autoradiographic studies.

Authors:  K Gondo; T Ueno; M Sakamoto; S Sakisaka; M Sata; K Tanikawa
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

  10 in total
  3 in total

1.  Description of a Recovery Model in Rabbits for the Study of the Late Phase of Liver Ischemia-Reperfusion Injury.

Authors:  Athina G Mantelou; Argyro Zacharioudaki; George Pappas-Gogos; Apostolos Papalois; Alexandra Papoudou-Bai; Anna Goussia; Georgios K Glantzounis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 2.  The role of sulodexide in the treatment of diabetic nephropathy.

Authors:  Ram Weiss; Robert Niecestro; Itamar Raz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Role of hepatic stellate cells in liver ischemia-reperfusion injury.

Authors:  Yuming Peng; Qiang Yin; Miaoxian Yuan; Lijian Chen; Xinyi Shen; Weixin Xie; Jinqiao Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.